Microscopic view of human papillomavirus (HPV) particles

What Is HPV? Understanding the Basics

By: Emily Golden | Founder, Sacred Womb Healing | Updated March 2026 | 8-10 minute read
Educational Content. Sources Cited Below.

You may have just gotten results you weren’t expecting. Or maybe you have been sitting with this information for weeks, reading article after article, and still feeling like something is not fully clicking. HPV is often talked about like it is simple and nothing to stress over because it is so common, but for many women, that reassurance still leaves them walking out of appointments with more questions than answers.

This article exists to change that.

We’re going to go deeper than the surface-level explanation. We’re going to talk about what HPV actually is, how it behaves inside your body, why it sometimes clears and sometimes doesn’t, and what all of that means for you going forward. Not in a way that will overwhelm you, but in a way that actually makes sense

Understanding HPV Beyond the Basics

HPV stands for human papillomavirus. According to the CDC, HPV is not just one virus. It is a family of more than 200 related viral strains, each with different behaviors and different effects on the body.

What these strains do share is how they spread: through direct skin-to-skin contact. That distinction matters because it is often misunderstood. HPV is not passed only through penetrative sex. It can also spread through other forms of genital skin contact, which helps explain why the CDC estimates that nearly all sexually active people will have HPV at some point in their lives.

That number helps put HPV into perspective. It is an extremely common virus that most people’s immune systems encounter and, in many cases, manage without lasting effects. What matters most, and what this article is really about, is how your body responds to it.

What Low-Risk and High-Risk HPV Actually Mean

Not all strains of HPV behave the same way. One of the most important clinical distinctions is the difference between low-risk and high-risk strains.

Low-risk strains, such as HPV 6 and 11, are associated with conditions like genital warts. According to the CDC, they are not linked to cervical cancer and are not the strains tracked in cervical screening.

High-risk strains, including HPV 16, 18, 31, 33, and 45, are the ones linked to cellular changes in the cervix over time. These are the strains your provider is referring to when they mention high-risk HPV on a test result.

Here is what is important to understand about that phrase: high-risk does not mean harm is inevitable. It means the strain can affect cervical cells in ways that, over time and under the right conditions, may lead to abnormal changes. Even then, many high-risk HPV infections still clear without progressing to dysplasia. Even then, many high-risk HPV infections still clear without progressing to dysplasia. This is important for monitoring, not creating panic. 

The National Cancer Institute notes that persistent infection with high-risk strains, especially HPV 16 and 18, is associated with the majority of cervical cancer cases worldwide. But “associated with” and “guaranteed to cause” are not the same thing. That is an important distinction to remember.

How HPV Affects Cervical Cells

To understand how HPV affects cervical cells, it helps first to understand why the cervix is especially vulnerable to infection. The cervix contains an area called the transformation zone, where the cells on the outer surface of the cervix meet the cells lining the inner cervical canal. The National Cancer Institute notes that the transformation zone is especially vulnerable to HPV infection because it is an area of constant cellular change and renewal. When HPV enters this region, it reaches the basal cells, which are the deepest cells in the cervical lining.

Once inside, the virus does not immediately cause visible changes. HPV works slowly. Over time, it interferes with the normal function of infected cells and begins producing proteins that can change how those cells grow and divide. This is part of how HPV connects to cervical dysplasia, a process that usually unfolds over months or even years rather than days. This is why a persistent infection tells us more than a single positive test. That slower timeline matters, especially if you are feeling a sense of urgency right now. A positive HPV result does not tell the whole story, and persistence does not mean your body has failed. It means the infection is still present and that your body may need more support, more time, or both.

E6 and E7 Proteins: How HPV Disrupts Normal Cell Behavior

This is where the science gets more technical, but it is also where HPV starts to make a lot more sense. Your body has built-in safety systems that constantly monitor cell health. When a cell is damaged or starts behaving abnormally, those systems send signals to stop dividing, repair itself, or undergo programmed cell death. These are normal protective functions happening in the background all the time. According to Yeo-Teh and colleagues, high-risk HPV strains produce two proteins called E6 and E7 that interfere with this process.

The E6 protein targets a tumor-suppressing protein called p53. Under normal conditions, p53 acts like a quality-control checkpoint. It helps detect abnormal cells and signals them to stop dividing or self-destruct. Yeo-Teh and colleagues explain that E6 promotes the breakdown of p53, which weakens that checkpoint. When damaged cells do not receive the signal to stop, they can continue to replicate.

The E7 protein interferes with another regulatory protein called pRb, which normally helps keep cell division under control. The same review explains that E7 disrupts pRb, pushing cells to divide when they otherwise would not.

Together, E6 and E7 create conditions that allow abnormal cells to accumulate rather than be cleared. This is part of the reason persistent high-risk HPV infection can, over time, lead to precancerous cell changes known as cervical dysplasia, or CIN. It is important to keep in mind that this does not happen in every case. It usually requires a persistent infection over time, along with other factors that can affect how the body responds. 

Understanding HPV Dormancy and Reactivation

One of the most confusing things about HPV is that it does not always behave in a straight line. A person can test negative for years and then test positive later in life without any new exposure. That does not automatically mean something new happened. It is part of how HPV can behave in the body. Research by Gravitt describes this as latency, a state in which the virus can remain in the tissue at levels too low to be detected by standard testing.

When the immune system suppresses HPV, that does not always mean the virus has been fully eliminated. In some cases, it may remain in a controlled, nonproductive state and become detectable again later. Gravitt’s review notes that this pattern helps explain why HPV can seem to disappear and reappear over time.

What can shift that balance is still being studied, but observational research points to several possible influences on reactivation, including immune suppression, hormonal shifts, and chronic stress. Research on stress also suggests that ongoing psychological strain can affect how well the immune system regulates and monitors infections, which may help explain why prolonged stress can matter in the context of HPV persistence.

A positive HPV result later in life is not automatic proof of a new transmission. It highlights how much the body’s internal environment matters. HPV is not only about exposure. It is also about what is happening with immune regulation, recovery, and the conditions that make it easier or harder for the virus to stay quiet.

How the Immune System Responds to HPV

The immune system is central to what happens next with HPV, so it helps to understand how that process actually works. According to the CDC, most HPV infections resolve on their own within two years. In this context, “cleared” does not necessarily mean the virus has been permanently erased from every cell. It usually means the viral load has dropped below the level that standard testing can detect and that the body has brought the infection under control.

This is an active immune process. The body has to recognize HPV-infected cells, mount a response, and continue monitoring over time. That response is not shaped by one factor alone. It appears to be influenced by the broader internal environment of the body, including nutrient status, chronic stress, smoking exposure, and hormonal shifts that can affect immune regulation.

Nutrition has been studied as one possible part of that picture, though the evidence is still developing. Some observational studies, including research by Piyathilake and colleagues, suggest that folate and vitamin B12 status may influence how high-risk HPV behaves over time and how likely cervical cell changes are to develop. That does not make these nutrients magic fixes, but it does suggest that deficiencies and depletion may matter more than many women are told.

Chronic stress is another important factor. Research suggests that ongoing psychological strain can disrupt immune regulation and shift the type of immune response the body can mount, which may help explain why long periods of stress can matter when the body is trying to keep HPV suppressed. Hormonal shifts may also play a role, especially during pregnancy and the postpartum period, when the immune system is adapting in real time.

Smoking is another meaningful piece of the picture. The CDC notes that cigarette smoking is associated with cervical precancer and cancer in women with HPV, and the broader research has long identified smoking as a cofactor in the development of cervical cell changes.
This is where the focus on supporting immune health comes from. Not as a replacement for medical monitoring, but as another meaningful piece of the picture grounded in what the research actually shows.

Why Men Typically Aren’t Tested for HPV

There is currently no routine FDA-cleared HPV test used to screen men the way cervical HPV testing is used in women. As the CDC explains, the HPV tests cleared in the United States are approved for cervical specimens, not for use in screening the male genital tract, and current guidance does not recommend HPV testing for partners or for diagnosing genital warts.
Because HPV in men is often asymptomatic and there is no standardized screening approach for the male genital tract that has shown clear benefit at the population level, routine HPV screening for men has not become part of standard public health practice. As a result, male HPV screening remains far more limited than cervical screening in women.

What this creates in practice is an imbalance: women often go through regular cervical screening that can detect both HPV and cell changes, while male partners usually do not receive any equivalent routine monitoring. That leaves women carrying a disproportionate share of the diagnostic and emotional burden of a virus that is shared between partners.

A positive HPV result does not automatically mean anyone was dishonest or careless. HPV is common, often silent, and not routinely screened for in men the way it is in women. That makes it easy for fear and suspicion to fill in the blanks, even when the test itself cannot tell you when the virus was acquired or from whom.

What This Actually Means for You

By this point, the goal is not just that you understand HPV better. It is that you see your situation more clearly. HPV is common. In many cases, the immune system does clear it over time. Not every high-risk strain leads to dysplasia, and not every case of dysplasia progresses. This process usually unfolds over months or years, not overnight. That matters because fear tends to collapse everything into a sense of urgency, even though reality is often more layered than that.

None of that means ignoring what is happening or stepping away from medical follow-up. Ongoing monitoring matters because HPV outcomes vary by individual, and tracking cellular changes over time helps guide appropriate care when needed.

But it also means your situation is not as hopeless or one-dimensional as many women are led to believe in the first shock of diagnosis. You are not powerless here. You have context now. You understand more about how this virus behaves, what persistence actually means, and why the body’s condition matters. That does not guarantee any one outcome, but it does give you a more honest and grounded way to move forward.

All claims in this article are supported by peer-reviewed research or authoritative public health sources. Full citations are listed below 

1. Centers for Disease Control and Prevention. (2023). Human papillomavirus (HPV). https://www.cdc.gov/hpv

2. Cohen, S., Janicki-Deverts, D., & Miller, G. E. (2007). Psychological stress and disease. JAMA, 298(14), 1685–1687. https://doi.org/10.1001/jama.298.14.1685

3. Giuliano, A. R., Palefsky, J. M., Goldstone, S., Moreira, E. D., Jr., Penny, M. E., Aranda, C., Vardas, E., Moi, H., Jessen, H., Hillman, R., Chang, Y. H., Ferris, D., Rouleau, D., Bryan, J., Marshall, J. B., Vuocolo, S., Barr, E., Radley, D., Haupt, R. M., & Guris, D. (2011). Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. New England Journal of Medicine, 364(5), 401–411. https://doi.org/10.1056/NEJMoa0909537

4. Gravitt, P. E. (2011). The known unknowns of HPV natural history. Journal of Clinical Investigation, 121(12), 4593–4599. https://doi.org/10.1172/JCI57149

5. Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998). Natural history of cervicovaginal papillomavirus infection in young women. New England Journal of Medicine, 338(7), 423–428. https://doi.org/10.1056/NEJM199802123380703

6. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. (2012). Biological agents: A review of human carcinogens (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 100B). International Agency for Research on Cancer.

7. Moscicki, A. B., Schiffman, M., Kjaer, S., & Villa, L. L. (2004). Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine, 24(Suppl 3), S42–S51. https://doi.org/10.1016/j.vaccine.2006.06.008

8. National Cancer Institute. (2023). HPV and cancer. https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer

9. Piyathilake, C. J., Macaluso, M., Chambers, M. M., Johanning, G. L., Heimburger, D. C., & Partridge, E. E. (2004). Racial differences in the association of folate, vitamin B-12, and other micronutrients with cervical intraepithelial neoplasia. Nutrition and Cancer, 50(2), 123–130. https://doi.org/10.1207/s15327914nc5002_1

10. Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016). Carcinogenic human papillomavirus infection. Nature Reviews Disease Primers, 2, 16086. https://doi.org/10.1038/nrdp.2016.86

11. Yeo-Teh, N. S. L., Ito, Y., & Jha, S. (2018). High-risk human papillomaviral oncogenes E6 and E7 target key cellular pathways to achieve oncogenesis. International Journal of Molecular Sciences, 19(6), 1706. https://doi.org/10.3390/ijms19061706

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *